Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
30
NCT04956744
A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 31, 2021
Completion: Dec 31, 2027